Immunome, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 18.21 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.07B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
Details
| Name | Immunome, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 247 |
| Founded | 2006 |
| Ipo Date | 2020-10-02 |
| Ceo | Clay Siegall |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 12.00 |
| Isin | US45257U1088 |
| Cusip | 45257U108 |
| Cik | 1472012 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Clay B. Siegall Ph.D. | Chairman, President and Chief Executive Officer |
| Max Rosett | Chief Financial Officer |
| Dr. Robert J. Lechleider M.D. | Chief Medical Officer |
| Dr. Philip Tsai | Chief Technical Officer |
| Dr. Jack Higgins Ph.D. | Chief Scientific Officer |
| Sandra G. Stoneman Esq., J.D. | Chief Legal Officer, General Counsel and Corporate Secretary |
| Roee Shahar | Executive Vice President of Commercial |
Contact
| Address | 18702 North Creek Parkway, Suite 100, Bothell, Washington 98011, United States |
| Phone | 425 939 7410 |
| Website | https://immunome.com |